GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Pre-Tax Income

ProKidney (MEX:PROK) Pre-Tax Income : MXN-2,202.13 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProKidney Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. ProKidney's pretax income for the three months ended in Mar. 2024 was MXN-584.77 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was MXN-2,202.13 Mil. ProKidney's pretax margin was %.


ProKidney Pre-Tax Income Historical Data

The historical data trend for ProKidney's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Pre-Tax Income Chart

ProKidney Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
-536.71 -1,130.49 -2,870.57 -2,197.33

ProKidney Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -641.37 -580.46 -715.53 -321.37 -584.77

Competitive Comparison of ProKidney's Pre-Tax Income

For the Biotechnology subindustry, ProKidney's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProKidney's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProKidney's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where ProKidney's Pre-Tax Income falls into.



ProKidney Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

ProKidney's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2571.972+0+-0.204+374.842+0.0010000000002037
=-2,197.33

ProKidney's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-665.112+0+-0.033+80.376+0
=-584.77

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-2,202.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ProKidney  (MEX:PROK) Pre-Tax Income Explanation

ProKidney's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-584.769/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ProKidney Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of ProKidney's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


ProKidney (MEX:PROK) Business Description

Traded in Other Exchanges
Address
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.